Clinician scientists collaborate to use virus-specific T-cells from the mother to successfully treat a systemic adenovirus infection in a preterm infant.
Clinician scientists collaborate to use virus-specific T-cells from the mother to successfully treat a systemic adenovirus infection in a preterm infant.
NK cells are an important part of the strategy to manipulate the immune system to fight cancer. Making TGFβ-resistant NK cells is a step toward improving their activity against it.
